Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat
The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an e...
Gespeichert in:
Veröffentlicht in: | Experimental neurology 2007-05, Vol.205 (1), p.36-47 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 47 |
---|---|
container_issue | 1 |
container_start_page | 36 |
container_title | Experimental neurology |
container_volume | 205 |
creator | Breit, S. Bouali-Benazzouz, R. Popa, R.C. Gasser, T. Benabid, A.L. Benazzouz, A. |
description | The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization. |
doi_str_mv | 10.1016/j.expneurol.2006.12.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19372621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488606006534</els_id><sourcerecordid>19372621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-575a254b81f62f73cac0783bee82261c92f30b0e214392f36b8d4e6a1a01e6b73</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi1ERbeFV4Bc4JbgP4mTHKuqpZUqcaFna-JMWC_eONjOtnkY3hWnu6JHTrbm-32eGX-EfGK0YJTJr7sCn6cRZ-9swSmVBeNFqr8hG0ZbmvNS0LdkQykr87Jp5Dm5CGFHKW1LXr8j56wWbcUatiF_boYBdQyZGzKZb5feu-eldxPszYi5GftZY58FPKDHzPlsAh8N2MxiMG5cXXGL2Wh-eheiNxCTNkHcPsGSJf1FXMccUx10NAcTl9U1gbWmd3mYu7gFm9rpBMYn539l5ujzEN-TswFswA-n85I83t78uL7LH75_u7--esh1WjTmVV0Br8quYYPkQy00aFo3okNsOJdMt3wQtKPIWSnWu-yavkQJDChD2dXiknw5vjt593vGENXeBI3WwohuDoq1ouaSswTWR1CnfYPHQU3e7MEvilG1JqN26l8yak1GMa5SPTk_nlrM3R77V98pigR8PgEQNNjBw6hNeOWauhKiWWe9OnKYPuRg0KugDY4pJuNTkqp35r_D_AWeO7Sz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19372621</pqid></control><display><type>article</type><title>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Breit, S. ; Bouali-Benazzouz, R. ; Popa, R.C. ; Gasser, T. ; Benabid, A.L. ; Benazzouz, A.</creator><creatorcontrib>Breit, S. ; Bouali-Benazzouz, R. ; Popa, R.C. ; Gasser, T. ; Benabid, A.L. ; Benazzouz, A.</creatorcontrib><description>The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2006.12.016</identifier><identifier>PMID: 17395181</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>6-Hydroxydopamine ; Animals ; Biological and medical sciences ; Corpus Striatum - pathology ; Disease Progression ; Dopamine - metabolism ; Drug toxicity and drugs side effects treatment ; Electrophysiology ; Extracellular recordings ; Globus pallidus ; Globus Pallidus - physiopathology ; Injuries of the nervous system and the skull. Diseases due to physical agents ; Male ; Medical sciences ; Microinjections ; Nerve Fibers - pathology ; Nerve Net - physiopathology ; Neurons ; Oxidopamine - administration & dosage ; Parkinson Disease, Secondary - chemically induced ; Parkinson Disease, Secondary - pathology ; Parkinson Disease, Secondary - physiopathology ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Striatum ; Substantia Nigra - metabolism ; Substantia Nigra - pathology ; Substantia nigra pars compacta ; Subthalamic nucleus ; Subthalamic Nucleus - physiopathology ; Toxicity: nervous system and muscle ; Traumas. Diseases due to physical agents</subject><ispartof>Experimental neurology, 2007-05, Vol.205 (1), p.36-47</ispartof><rights>2007 Elsevier Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-575a254b81f62f73cac0783bee82261c92f30b0e214392f36b8d4e6a1a01e6b73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014488606006534$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18753387$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17395181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Breit, S.</creatorcontrib><creatorcontrib>Bouali-Benazzouz, R.</creatorcontrib><creatorcontrib>Popa, R.C.</creatorcontrib><creatorcontrib>Gasser, T.</creatorcontrib><creatorcontrib>Benabid, A.L.</creatorcontrib><creatorcontrib>Benazzouz, A.</creatorcontrib><title>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.</description><subject>6-Hydroxydopamine</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Corpus Striatum - pathology</subject><subject>Disease Progression</subject><subject>Dopamine - metabolism</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Electrophysiology</subject><subject>Extracellular recordings</subject><subject>Globus pallidus</subject><subject>Globus Pallidus - physiopathology</subject><subject>Injuries of the nervous system and the skull. Diseases due to physical agents</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microinjections</subject><subject>Nerve Fibers - pathology</subject><subject>Nerve Net - physiopathology</subject><subject>Neurons</subject><subject>Oxidopamine - administration & dosage</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Parkinson Disease, Secondary - pathology</subject><subject>Parkinson Disease, Secondary - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Striatum</subject><subject>Substantia Nigra - metabolism</subject><subject>Substantia Nigra - pathology</subject><subject>Substantia nigra pars compacta</subject><subject>Subthalamic nucleus</subject><subject>Subthalamic Nucleus - physiopathology</subject><subject>Toxicity: nervous system and muscle</subject><subject>Traumas. Diseases due to physical agents</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxi1ERbeFV4Bc4JbgP4mTHKuqpZUqcaFna-JMWC_eONjOtnkY3hWnu6JHTrbm-32eGX-EfGK0YJTJr7sCn6cRZ-9swSmVBeNFqr8hG0ZbmvNS0LdkQykr87Jp5Dm5CGFHKW1LXr8j56wWbcUatiF_boYBdQyZGzKZb5feu-eldxPszYi5GftZY58FPKDHzPlsAh8N2MxiMG5cXXGL2Wh-eheiNxCTNkHcPsGSJf1FXMccUx10NAcTl9U1gbWmd3mYu7gFm9rpBMYn539l5ujzEN-TswFswA-n85I83t78uL7LH75_u7--esh1WjTmVV0Br8quYYPkQy00aFo3okNsOJdMt3wQtKPIWSnWu-yavkQJDChD2dXiknw5vjt593vGENXeBI3WwohuDoq1ouaSswTWR1CnfYPHQU3e7MEvilG1JqN26l8yak1GMa5SPTk_nlrM3R77V98pigR8PgEQNNjBw6hNeOWauhKiWWe9OnKYPuRg0KugDY4pJuNTkqp35r_D_AWeO7Sz</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Breit, S.</creator><creator>Bouali-Benazzouz, R.</creator><creator>Popa, R.C.</creator><creator>Gasser, T.</creator><creator>Benabid, A.L.</creator><creator>Benazzouz, A.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20070501</creationdate><title>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</title><author>Breit, S. ; Bouali-Benazzouz, R. ; Popa, R.C. ; Gasser, T. ; Benabid, A.L. ; Benazzouz, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-575a254b81f62f73cac0783bee82261c92f30b0e214392f36b8d4e6a1a01e6b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>6-Hydroxydopamine</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Corpus Striatum - pathology</topic><topic>Disease Progression</topic><topic>Dopamine - metabolism</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Electrophysiology</topic><topic>Extracellular recordings</topic><topic>Globus pallidus</topic><topic>Globus Pallidus - physiopathology</topic><topic>Injuries of the nervous system and the skull. Diseases due to physical agents</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microinjections</topic><topic>Nerve Fibers - pathology</topic><topic>Nerve Net - physiopathology</topic><topic>Neurons</topic><topic>Oxidopamine - administration & dosage</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Parkinson Disease, Secondary - pathology</topic><topic>Parkinson Disease, Secondary - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Striatum</topic><topic>Substantia Nigra - metabolism</topic><topic>Substantia Nigra - pathology</topic><topic>Substantia nigra pars compacta</topic><topic>Subthalamic nucleus</topic><topic>Subthalamic Nucleus - physiopathology</topic><topic>Toxicity: nervous system and muscle</topic><topic>Traumas. Diseases due to physical agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Breit, S.</creatorcontrib><creatorcontrib>Bouali-Benazzouz, R.</creatorcontrib><creatorcontrib>Popa, R.C.</creatorcontrib><creatorcontrib>Gasser, T.</creatorcontrib><creatorcontrib>Benabid, A.L.</creatorcontrib><creatorcontrib>Benazzouz, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Breit, S.</au><au>Bouali-Benazzouz, R.</au><au>Popa, R.C.</au><au>Gasser, T.</au><au>Benabid, A.L.</au><au>Benazzouz, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>205</volume><issue>1</issue><spage>36</spage><epage>47</epage><pages>36-47</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>17395181</pmid><doi>10.1016/j.expneurol.2006.12.016</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4886 |
ispartof | Experimental neurology, 2007-05, Vol.205 (1), p.36-47 |
issn | 0014-4886 1090-2430 |
language | eng |
recordid | cdi_proquest_miscellaneous_19372621 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | 6-Hydroxydopamine Animals Biological and medical sciences Corpus Striatum - pathology Disease Progression Dopamine - metabolism Drug toxicity and drugs side effects treatment Electrophysiology Extracellular recordings Globus pallidus Globus Pallidus - physiopathology Injuries of the nervous system and the skull. Diseases due to physical agents Male Medical sciences Microinjections Nerve Fibers - pathology Nerve Net - physiopathology Neurons Oxidopamine - administration & dosage Parkinson Disease, Secondary - chemically induced Parkinson Disease, Secondary - pathology Parkinson Disease, Secondary - physiopathology Pharmacology. Drug treatments Rats Rats, Wistar Striatum Substantia Nigra - metabolism Substantia Nigra - pathology Substantia nigra pars compacta Subthalamic nucleus Subthalamic Nucleus - physiopathology Toxicity: nervous system and muscle Traumas. Diseases due to physical agents |
title | Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A47%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%206-hydroxydopamine-induced%20severe%20or%20partial%20lesion%20of%20the%20nigrostriatal%20pathway%20on%20the%20neuronal%20activity%20of%20pallido-subthalamic%20network%20in%20the%20rat&rft.jtitle=Experimental%20neurology&rft.au=Breit,%20S.&rft.date=2007-05-01&rft.volume=205&rft.issue=1&rft.spage=36&rft.epage=47&rft.pages=36-47&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1016/j.expneurol.2006.12.016&rft_dat=%3Cproquest_cross%3E19372621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19372621&rft_id=info:pmid/17395181&rft_els_id=S0014488606006534&rfr_iscdi=true |